| CONTACTS: |
César García,
President and Chief Executive Officer |
|
818-709-1244 x 7123
|
|
-or-
|
|
Ron Stabiner, The Wall Street Group, Inc. |
|
212-888-4848 |
CHATSWORTH, Calif., May 31, 2007 - IRIS International, Inc. (NASDAQ GM: IRIS)
today announced that President and Chief Executive Officer César García will deliver a presentation to investors at The New York Society of Security Analysts 2007 Medical Devices Conference, to be
held at the Society's headquarters, 1177 Avenue of the Americas in New York City, on Tuesday, June 12, 2007 at 10:15 a.m. Eastern time.
The archived webcast of the IRIS presentation for this conference will be posted to the NYSSA website several days after its conclusion, and will remain on the site for one
year. It will be available to NYSSA Members and Conference attendees. For more information, please visit the NYSSA website at:
www.nyssa.org/Content/NavigationMenu/programs/webcasts/webcasts.htm
ABOUT NYSSA
NYSSA, established in 1937, is the premier independent forum for the exchange of information among investment decision-makers. A not-for-profit educational organization with over 9,500
members, NYSSA is committed to the promotion of best practices and the highest professional and ethical standards in the investment industry. NYSSA is the largest of the more than 134 societies worldwide
that make up CFA Institute, which has more than 83,000 members.
THE COMPANY
IRIS International, Inc. (www.proiris.com), based in Chatsworth, Calif., is a leading developer, manufacturer, and marketer of
medical devices, diagnostic systems and consumables. The Iris Diagnostics Division (www.irisdiagnostics.com) is a leader in automated
urinalysis technology with systems in major medical institutions throughout the world. The Company's Sample Processing business unit (formerly the StatSpin® subsidiary)
(www.statspin.com), based in Westwood, Mass., manufactures innovative centrifuges and blood analysis products. The Iris Molecular Diagnostics (IMD)
Subsidiary, based in San Diego, Calif., develops innovative ultra-sensitive diagnostics and sample processing products with applications in the urinalysis, oncology and infectious disease markets.
